Impedimed Limited Stock Today
| IPDQF Stock | USD 0.05 0.01 43.32% |
Performance10 of 100
| Odds Of DistressLess than 39
|
ImpediMed is trading at 0.0483 as of the 30th of November 2024. This is a 43.32 percent increase since the beginning of the trading day. The stock's lowest day price was 0.0483. ImpediMed has about a 39 percent probability of financial distress in the next few years of operation but had a somewhat ok performance during the last 90 days. Equity ratings for ImpediMed Limited are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of June 2024 and ending today, the 30th of November 2024. Click here to learn more.
ImpediMed Limited, a medical software technology company, develops, manufactures, and sells bioimpedance spectroscopy devices and software services in Australia, North America, and internationally. The company was incorporated in 1999 and is headquartered in Pinkenba, Australia. The company has 1.79 B outstanding shares. More on ImpediMed Limited
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
ImpediMed Pink Sheet Highlights
| Business Concentration | Medical Devices, Healthcare (View all Sectors) |
ImpediMed Limited [IPDQF] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC). The company currently falls under 'Micro-Cap' category with a current market capitalization of 78.57 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ImpediMed's market, we take the total number of its shares issued and multiply it by ImpediMed's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. ImpediMed Limited classifies itself under Healthcare sector and is part of Medical Devices industry. The entity has 1.79 B outstanding shares.
ImpediMed Limited has accumulated about 40.73 M in cash with (15.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02.
Check ImpediMed Probability Of Bankruptcy
Ownership AllocationImpediMed Limited has a total of 1.79 Billion outstanding shares. ImpediMed retains 13.73 (percent) of its outstanding shares held by insiders and 14.96 (percent) owned by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check ImpediMed Ownership Details
ImpediMed Limited Risk Profiles
| Mean Deviation | 9.18 | |||
| Semi Deviation | 11.14 | |||
| Standard Deviation | 24.2 | |||
| Variance | 585.72 |
ImpediMed Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in ImpediMed without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Instant Ratings Now
Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
ImpediMed Corporate Management
| Nancy Deisinger | VP HR | Profile | |
| Timothy Cruickshank | Chief Officer | Profile | |
| Michael Bassett | Sr Officer | Profile | |
| Shashi Tripathi | CTO COO | Profile | |
| Walton Taylor | Medical Director | Profile | |
| Richard Valencia | MD CEO | Profile |
Other Information on Investing in ImpediMed Pink Sheet
ImpediMed financial ratios help investors to determine whether ImpediMed Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ImpediMed with respect to the benefits of owning ImpediMed security.